Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Further funding for Tecnobiomedica:

This article was originally published in Clinica

Executive Summary

Tecnobiomedica, the Italian organisation aiming to develop a permanently implantable artificial heart, is looking forward to a further injection of funds in the shape of a government research contract this month. According to Il Sole-24 Ore, Lit 75 billion ($48 million) is to be allocated to the "Cardiology 2" programme, which includes the Tecnobiomedica project in which Sorin Biomedica, Esaote Biomedica, Nuova Sias and Dideco are involved. They are supported by other small and medium-sized companies, as well as universities and research centres.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts